adriana fantini

Dr. adriana fantini

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AFadriana fantini
adriana fantini
ADAnna Demurtas
Anna Demurtas
Sara NicoliSara Nicoli
Sara Nicoli
CPCristina Padula
Cristina Padula
Silvia PescinaSilvia Pescina
Silvia Pescina
PSPatrizia Santi
Patrizia Santi
Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied in vitro from a 2% ointment using porcine skin as barrier. Crisaborole was also characterized in terms of thermal behavior, solubility, and logP. Control experiments were performed also on tape stripped skin to clarify the role of stratum corneum in drug partitioning and permeation across the skin. The results obtained indicate that crisaborole accumulates into the skin in considerable amounts after application of a topical lipophilic ointment. Crisaborole shows more affinity for the dermis compared to the epidermis despite its relatively high value of partition coefficient; stratum corneum analysis revealed a low affinity of the drug for this skin layer. Skin penetration across hair follicles or sebaceous glands can be a reason for the high dermis retention and is worth further investigation. The comparison with data obtained from a solution in acetonitrile suggests that the formulation plays a certain role in determining the relative distribution of crisaborole in the skin layers and in the receptor compartment.

5 April 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MGMartina Ghezzi
Martina Ghezzi
IFIlaria Ferraboschi
Ilaria Ferraboschi
AFadriana fantini
adriana fantini
Silvia PescinaSilvia Pescina
Silvia Pescina
CPCristina Padula
Cristina Padula
Sara NicoliSara Nicoli
Sara Nicoli

30 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AFadriana fantini
adriana fantini
LGLuca Giulio
Luca Giulio
ADAndrea Delledonne
Andrea Delledonne
Silvia PescinaSilvia Pescina
Silvia Pescina
Cristina SissaCristina Sissa
Cristina Sissa
CPCristina Padula
Cristina Padula
The greatest achievement in the advanced drug delivery field should be the optimization of non-invasive formulations for the delivery of high molecular weight compounds. Peptides, proteins, and other macromolecules can have poor membrane permeation, principally due to their large molecular weight. The aim of this work was to explore the possibility of administering fluorescently labeled dextrans (molecular weight 4–150 kDa) across the buccal mucosa. Permeation experiments across pig esophageal mucosa were carried out using fatty acids and bile salts as penetration enhancers. The data obtained show that it is possible to increase or promote the mucosa permeation of high molecular weight dextrans by using caprylic acid or sodium taurocholate as the chemical enhancers. With these enhancers, dextrans with molecular weight of 70 and 150 kDa, that in passive conditions did not permeate, could cross the mucosa in detectable amounts. FD-70 and FD-150 showed comparable permeability values, despite the molecular weight difference. The results obtained in the present work suggest that the buccal administration of high molecular weight compounds is feasible.

1 June 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AFadriana fantini
adriana fantini
CPCristina Padula
Cristina Padula
Sara NicoliSara Nicoli
Sara Nicoli
SPSilvia Pescina
Silvia Pescina
PSPatrizia Santi
Patrizia Santi

25 January 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AFadriana fantini
adriana fantini
ADAndrea Delledonne
Andrea Delledonne
Luca CasulaLuca Casula
Luca Casula
Sara NicoliSara Nicoli
Sara Nicoli
Silvia PescinaSilvia Pescina
Silvia Pescina
CPCristina Padula
Cristina Padula
Objectives: This work aimed at investigating the effect of different microneedle-based strategies on the permeation of high-molecular-weight model molecules (fluorescently labeled dextrans (FDs), 70 and 150 kDa) across the buccal mucosa. Methods: Two different approaches were evaluated: (1) stainless steel microneedles (MNs) of 500 µm height used for tissue pre-treatment; and (2) soluble microneedles of different lengths (150, 500, and 800 µm), made of polyvinylpyrrolidone and FDs, prepared using the solvent casting technique. Porcine esophageal epithelium was used as a model for the buccal mucosa. Results: The application of soluble MNs promoted high-molecular-weight dextran transport across pig esophageal epithelium. The transport was proportional to MN length, with a minimum of 500 µm, regardless of the molecular weight of the FDs. The use of solid MNs of the same length to pre-treat the tissue, followed by the application of a solution of the permeant, did not produce the same effect in terms of onset of permeation, which was found to be much slower. Conclusions: The results obtained show that by applying soluble MNs of appropriate length (500 and 800 µm), the transport of high-molecular-weight dextrans (70 and 150 kDa) across and into the mucosal tissue occurs very rapidly. The multiphoton microscopy analysis confirmed the presence of holes in the tissue and the presence of fluorescein-labeled dextrans.